Egypt, Arab Republic of vs Guinea: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Egypt, Arab Republic of
0.0%
in 2025
Guinea
0.0%
in 2025
Egypt, Arab Republic of rank
165th
Guinea rank
165th
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Egypt, Arab Republic of
- Guinea
How they compare
Egypt, Arab Republic of currently reports 0.0% against 0.0% in Guinea, a difference of 0.0%.
Across all 18 years both countries report, Guinea has been ahead every year.
Egypt, Arab Republic of ranks 165th and Guinea ranks 165th of 192 countries.
Head to head by decade
| Decade | Egypt, Arab Republic of | Guinea | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 0.0% | 0.0% | 0.0% | — |
| 2020s | 0.0% | 0.0% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Egypt, Arab Republic of or Guinea?
- Egypt, Arab Republic of, at 0.0% against 0.0% in Guinea as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Egypt, Arab Republic of and Guinea?
- 0.0%, with Egypt, Arab Republic of ahead.
- How many years of comparable data are there for Egypt, Arab Republic of and Guinea?
- 18 years are reported by both, from 2008 to 2025.
- How do Egypt, Arab Republic of and Guinea rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Egypt, Arab Republic of ranks 165th and Guinea ranks 165th of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.